PharVision Advisers
NUS icon

PharVision Advisers’s Nu Skin NUS Stock Holding History

PharVision Advisers’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-13,202
Closed -$69.7K – 57
2026
Q2 		$69.7K Buy
+13,202
New +$84.4K 1.31% 45
2025
Q1 		– Sell
-81,429
Closed -$561K – 445
2024
Q4 		$561K Buy
+81,429
New +$560K 0.47% 28

Other funds holding NUS

PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
SummerHaven Investment Management
SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

PharVision Advisers's NUS Position: Q3 2026 in Review

PharVision Advisers sold out of Nu Skin (NUS) in Q3 2026, closing a stake of 13,202 shares — an estimated $69.7K sold.

PharVision Advisers first reported a position in NUS in Q4 2024 and held it in 2 quarters. The position peaked at $561K in Q4 2024. 54 funds tracked by Wall St. Rank hold NUS as of Q3 2026.

  • PharVision Advisers reported no remaining Nu Skin position as of Q3 2026 after selling out during the quarter.
  • PharVision Advisers sold 13,202 Nu Skin shares in Q3 2026, an estimated $69.7K.
  • PharVision Advisers first reported a position in Nu Skin in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Nu Skin position peaked at $561K in Q4 2024.
  • 54 funds tracked by Wall St. Rank held Nu Skin as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.